Form 4: Alignment Healthcare President Sells 30,000 Shares Under Pre-Arranged Plan

Dawn Christine Maroney, President of Alignment Healthcare, Inc., has sold 30,000 shares of common stock for approximately $434,280 under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Dawn Christine Maroney, President of Alignment Healthcare, Inc. (ALHC), disposed of 30,000 shares of common stock.
• The transaction occurred on June 16, 2025.
• The shares were sold at a weighted-average price of $14.476 per share, with prices ranging from $14.24 to $14.92.
• The total value of the shares sold is approximately $434,280.
• This sale was executed pursuant to a Rule 10b5-1 plan adopted on November 24, 2024.
• Following this transaction, Ms. Maroney beneficially owns 2,072,899 shares of Alignment Healthcare common stock.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to insider selling, but largely neutral given that the sale was pre-planned under a Rule 10b5-1 plan and represents a relatively small portion of the insider's total holdings, mitigating concerns about a lack of confidence.

Positives

• The sale was conducted under a Rule 10b5-1 plan, indicating it was a pre-scheduled transaction for personal financial planning rather than a reactive sale based on new negative information.

Negatives

• Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by investors as it may suggest a lack of confidence in the company's future prospects, although this is mitigated by the pre-planned nature.

Risks

• Potential negative investor sentiment due to insider selling, which could put downward pressure on the stock price.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing is a routine disclosure of an insider stock transaction and does not provide broader industry context or trends. It reflects an individual executive's personal financial planning rather than a company-wide strategic move.

Stakeholder Impact

• Shareholders: May interpret the insider sale as a signal, potentially leading to minor negative sentiment, though the 10b5-1 plan mitigates this.

Key Dates

Recommendation

Keywords

Alignment Healthcare, ALHC, Insider Trading, Form 4, Stock Sale, Executive Compensation, Beneficial Ownership, Rule 10b5-1 Plan